MARGARET HUSON

Medicare Sustainable Growth Rate (formula) SGR. H.R. 2356/S.1081, Preserving Patient Access to Physicians Act of 2005 S.1356, Medicare Value Purchasing Act of 2005 S.1002, The Hospital Fair Competition Act of 2005 - re. the moratorium on physician-owned specialty hospitals S.1932, Deficit Reduction Omnibus Reconciliation Act of 2005 (SGR relief) H.R. 3547/S.1840, Safety Net Inpatient Drug Affordability Act HR 3559, Medicare Durable Medical Equipment Access Act of 2005 S.1081/HR 2356, Preserving Patient Access to Physicians Act of 2005 S.1356, Medicare Value Purchasing Act of 2005

Kept Maryland Delegation apprised of concerns associated with the growing Medicare population and the pressures this presents for the healthcare system. Continued to appeal to CMS to adjust the Medicare Sustainable Growth Rate (formula) SGR. Met with HHS staff in the office of the Director for Medicare Services to discuss SGR and opportunities to design demo projects. Monitored the implementation of the Medicare Modernization Act – in particular, the new Part-D benefit. Also monitored: HR 2356/S. 1081”Preserving Patient Access to Physicians Act of 2005” ; S. 1356 “Medicare Value Purchasing ; S. 1002 “The Hospital Fair competition Act of 2005” re. the moratorium on physician-owned specialty hospitals; S. 354/ S. 366/S. 367/ HR 534 medical liability reform proposals; and Proposals related to “pay for performance” initiatives.

H.R. 810/S.471, Stem Cell Research Enhancement Act of 2005 S.658/H.R. 1357, Human Cloning Protection Act of 2005 S.1520, Human Cloning Ban Act of 2005 S.1373, Human Chimera Prohibition Act of 2005 S.470, Fair Access to Clinical Trials (FACT) Act of 2005

S.1418, Wired for Health Care Quality Act HR 3547, Safety Net Inpatient Drug Affordability Act

Communicated several issues concerning academic health centers to the Secretary of Health and Human Services and his office including: implementation of HIPAA rules, the development of regional electronic patient record systems, and concerns about physician reimbursement rates, medical liability, patient safety, bioterrorism and facilities and administration support. Worked in cooperation with AAMC and AHA to appeal to CMS to consider adjustments to the Medicare sustainable growth rate formula. Johns Hopkins is part of the Maryland/DC Collaborative for Healthcare Information Technology (formerly Maryland/DC E-Health Initiative) to develop and implement a regional electronic patient record system. Continue to keep all members of the Maryland Delegation apprised of the progress Monitored S. 1418 ‘Wired for Health Care Quality Access” Monitored S. 544 “Patient Safety & Quality Improvement Act of 2005” ,; monitored progress of medical liability reform proposals in the House and Senate; and monitored any Congressional activity that may result from recent court decisions regarding patent infringement claims. Also monitored: HR 869/S. 45 re. removing the statutory limit on physician group practices that treat substance abuse patients Advocated funding and monitored NIH and NSF budgets along with the Association of American Universities (AAU) and Association of American Medical Colleges (AAMC)-see budget section. Monitored amendments, which would potentially alter the funding of specific NIH-sponsored research projects that had undergone the established peer review processes. Continue to monitor legislative efforts on patient safety, physician reimbursement rates, quality improvement and medical liability.

H.R. 810/S.471, Stem Cell Research Enhancement Act of 2005 S.658/H.R. 1357, Human Cloning Protection Act of 2005 S.1520, Human Cloning Ban Act of 2005 S.1373, Human Chimera Prohibition Act of 2005 S.470, Fair Access to Clinical Trials (FACT) Act of 2005

H.R. 609, College Access and Opportunity Act of 2005 S.1932, Deficit Reduction Omnibus Reconciliation Act of 2005 (higher education title) S.1614, Higher Education Amendments of 2005 H.R. 507, College Access and Opportunity Act of 2005 STEM (Science, Technology, Engineering & Math) Education

H.R. 2830, Pension Protection Act of 2005 S.1783, Pension Security and Transparency Act of 2005

H.R. 2830, Pension Protection Act of 2005 S.1783, Pension Security and Transparency Act of 2005

Medicare Sustainable Growth Rate (formula) SGR. H.R. 2356/S.1081, Preserving Patient Access to Physicians Act of 2005 S.1356, Medicare Value Purchasing Act of 2005 S.1002, The Hospital Fair Competition Act of 2005 - re. the moratorium on physician-owned specialty hospitals S.1932, Deficit Reduction Omnibus Reconciliation Act of 2005 (SGR relief) H.R. 3547/S.1840, Safety Net Inpatient Drug Affordability Act HR 3559, Medicare Durable Medical Equipment Access Act of 2005 S.1081/HR 2356, Preserving Patient Access to Physicians Act of 2005 S.1356, Medicare Value Purchasing Act of 2005

Kept Maryland Delegation apprised of concerns associated with the growing Medicare population and the pressures this presents for the healthcare system. Continued to appeal to CMS to adjust the Medicare Sustainable Growth Rate (formula) SGR. Met with HHS staff in the office of the Director for Medicare Services to discuss SGR and opportunities to design demo projects. Monitored the implementation of the Medicare Modernization Act – in particular, the new Part-D benefit. Also monitored: HR 2356/S. 1081”Preserving Patient Access to Physicians Act of 2005” ; S. 1356 “Medicare Value Purchasing ; S. 1002 “The Hospital Fair competition Act of 2005” re. the moratorium on physician-owned specialty hospitals; S. 354/ S. 366/S. 367/ HR 534 medical liability reform proposals; and Proposals related to “pay for performance” initiatives.

Kept Maryland Delegation apprised of concerns associated with the growing Medicare population and the pressures this presents for the healthcare system. Continued to appeal to CMS to adjust the Medicare Sustainable Growth Rate (formula) SGR. Met with HHS staff in the office of the Director for Medicare Services to discuss SGR and opportunities to design demo projects. Monitored the implementation of the Medicare Modernization Act – in particular, the new Part-D benefit. Also monitored: HR 2356/S. 1081”Preserving Patient Access to Physicians Act of 2005” ; S. 1356 “Medicare Value Purchasing ; S. 1002 “The Hospital Fair competition Act of 2005” re. the moratorium on physician-owned specialty hospitals; S. 354/ S. 366/S. 367/ HR 534 medical liability reform proposals; and Proposals related to “pay for performance” initiatives.

Kept Maryland Delegation apprised of concerns associated with the growing Medicare population and the pressures this presents for the healthcare system. Continued to appeal to CMS to adjust the Medicare Sustainable Growth Rate (formula) SGR. Met with HHS staff in the office of the Director for Medicare Services to discuss SGR and opportunities to design demo projects. Monitored the implementation of the Medicare Modernization Act – in particular, the new Part-D benefit. Also monitored: HR 2356/S. 1081”Preserving Patient Access to Physicians Act of 2005” ; S. 1356 “Medicare Value Purchasing ; S. 1002 “The Hospital Fair competition Act of 2005” re. the moratorium on physician-owned specialty hospitals; S. 354/ S. 366/S. 367/ HR 534 medical liability reform proposals; and Proposals related to “pay for performance” initiatives.

Communicated several issues concerning academic health centers to the Secretary of Health and Human Services and his office including: implementation of HIPAA rules, the development of regional electronic patient record systems, and concerns about physician reimbursement rates, medical liability, patient safety, bioterrorism and facilities and administration support. Worked in cooperation with AAMC and AHA to appeal to CMS to consider adjustments to the Medicare sustainable growth rate formula. Johns Hopkins is part of the Maryland/DC Collaborative for Healthcare Information Technology (formerly Maryland/DC E-Health Initiative) to develop and implement a regional electronic patient record system. Continue to keep all members of the Maryland Delegation apprised of the progress Monitored S. 1418 ‘Wired for Health Care Quality Access” Monitored S. 544 “Patient Safety & Quality Improvement Act of 2005” ,; monitored progress of medical liability reform proposals in the House and Senate; and monitored any Congressional activity that may result from recent court decisions regarding patent infringement claims. Also monitored: HR 869/S. 45 re. removing the statutory limit on physician group practices that treat substance abuse patients Advocated funding and monitored NIH and NSF budgets along with the Association of American Universities (AAU) and Association of American Medical Colleges (AAMC)-see budget section. Monitored amendments, which would potentially alter the funding of specific NIH-sponsored research projects that had undergone the established peer review processes. Continue to monitor legislative efforts on patient safety, physician reimbursement rates, quality improvement and medical liability.

HR 810/S. 471 “The Stem Cell Research Enhancement Act of 2005” communicated with and met in person with House and Senate staff regarding the scientific and ethical implications of both embryonic and adult stem cell research; requested that members of the Maryland delegation co-sponsor the legislation; participated in advocacy activities in conjunction with the Coalition for the Advancement of Medical Research (CAMR), the Association of American Universities (AAU) and Association of American Medical Colleges (AAMC) towards the passage of the House bill and a strategy for passage in the Senate; Also monitored other stem cell related legislation , including that addressing: human cloning (S. 658/HR 1357) and regulation of so-called chimeras. Also monitored: S. 470 ‘Fair Access to Clinical Trials (FACT) Act of 2005) Responded to inquiries from the Maryland House delegation re. the participation of foster children in federally sponsored HIV/AIDS research protocols. Monitored issues involved with federal effort reporting requirements in conjunction with the Association of American Univiersities (AAU), the Amercian Association of Medical Colleges (AAMC), and the Council on Government Relations (COGR). In conjuction with efforts undertaken by the Association of American Medical Colleges (AAMC), prepared and submitted unsolicited comments related to new conflict of interest rules proposed by the Department of Health and Human Services with respect to employees of the National Institutes of Health

H.R. 810/S.471, Stem Cell Research Enhancement Act of 2005 S.658/H.R. 1357, Human Cloning Protection Act of 2005 S.1520, Human Cloning Ban Act of 2005 S.1373, Human Chimera Prohibition Act of 2005 S.470, Fair Access to Clinical Trials (FACT) Act of 2005

HR 810/S. 471 “The Stem Cell Research Enhancement Act of 2005” communicated with and met in person with House and Senate staff regarding the scientific and ethical implications of both embryonic and adult stem cell research; requested that members of the Maryland delegation co-sponsor the legislation; participated in advocacy activities in conjunction with the Coalition for the Advancement of Medical Research (CAMR), the Association of American Universities (AAU) and Association of American Medical Colleges (AAMC) towards the passage of the House bill and a strategy for passage in the Senate; Also monitored other stem cell related legislation , including that addressing: human cloning (S. 658/HR 1357) and regulation of so-called chimeras. Also monitored: S. 470 ‘Fair Access to Clinical Trials (FACT) Act of 2005) Responded to inquiries from the Maryland House delegation re. the participation of foster children in federally sponsored HIV/AIDS research protocols. Monitored issues involved with federal effort reporting requirements in conjunction with the Association of American Univiersities (AAU), the Amercian Association of Medical Colleges (AAMC), and the Council on Government Relations (COGR). In conjuction with efforts undertaken by the Association of American Medical Colleges (AAMC), prepared and submitted unsolicited comments related to new conflict of interest rules proposed by the Department of Health and Human Services with respect to employees of the National Institutes of Health

H.R. 810/S.471, Stem Cell Research Enhancement Act of 2005 S.658/H.R. 1357, Human Cloning Protection Act of 2005 S.1520, Human Cloning Ban Act of 2005 S.1373, Human Chimera Prohibition Act of 2005 S.470, Fair Access to Clinical Trials (FACT) Act of 2005

Communicated several issues concerning academic health centers to the Secretary of Health and Human Services and his office including: implementation of HIPAA rules, the development of regional electronic patient record systems, and concerns about physician reimbursement rates, medical liability, patient safety, bioterrorism and facilities and administration support. Worked in cooperation with AAMC and AHA to appeal to CMS to consider adjustments to the Medicare sustainable growth rate formula. Johns Hopkins is part of the Maryland/DC Collaborative for Healthcare Information Technology (formerly Maryland/DC E-Health Initiative) to develop and implement a regional electronic patient record system. Continue to keep all members of the Maryland Delegation apprised of the progress Monitored S. 1418 ‘Wired for Health Care Quality Access” Monitored S. 544 “Patient Safety & Quality Improvement Act of 2005” ,; monitored progress of medical liability reform proposals in the House and Senate; and monitored any Congressional activity that may result from recent court decisions regarding patent infringement claims. Also monitored: HR 869/S. 45 re. removing the statutory limit on physician group practices that treat substance abuse patients Advocated funding and monitored NIH and NSF budgets along with the Association of American Universities (AAU) and Association of American Medical Colleges (AAMC)-see budget section. Monitored amendments, which would potentially alter the funding of specific NIH-sponsored research projects that had undergone the established peer review processes. Continue to monitor legislative efforts on patient safety, physician reimbursement rates, quality improvement and medical liability.

H.R. 810/S.471, Stem Cell Research Enhancement Act of 2005 S.658/H.R. 1357, Human Cloning Protection Act of 2005 S.1520, Human Cloning Ban Act of 2005 S.1373, Human Chimera Prohibition Act of 2005 S.470, Fair Access to Clinical Trials (FACT) Act of 2005

HR 810/S. 471 “The Stem Cell Research Enhancement Act of 2005” communicated with and met in person with House and Senate staff regarding the scientific and ethical implications of both embryonic and adult stem cell research; requested that members of the Maryland delegation co-sponsor the legislation; participated in advocacy activities in conjunction with the Coalition for the Advancement of Medical Research (CAMR), the Association of American Universities (AAU) and Association of American Medical Colleges (AAMC) towards the passage of the House bill and a strategy for passage in the Senate; Also monitored other stem cell related legislation , including that addressing: human cloning (S. 658/HR 1357) and regulation of so-called chimeras. Also monitored: S. 470 ‘Fair Access to Clinical Trials (FACT) Act of 2005) Responded to inquiries from the Maryland House delegation re. the participation of foster children in federally sponsored HIV/AIDS research protocols. Monitored issues involved with federal effort reporting requirements in conjunction with the Association of American Univiersities (AAU), the Amercian Association of Medical Colleges (AAMC), and the Council on Government Relations (COGR). In conjuction with efforts undertaken by the Association of American Medical Colleges (AAMC), prepared and submitted unsolicited comments related to new conflict of interest rules proposed by the Department of Health and Human Services with respect to employees of the National Institutes of Health

HR 3010/S (not yet reported), “Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2006”: worked on the following items: an increase to the National Institutes of Health budget; amendments to the House-reported bill to eliminate funding of certain NIH grants already approved through the peer review processes; the advocacy effort for increased funding for extramural facilities construction through the National Institutes of Health. Also supported funding request for Critical Event Preparedness and Response (CEPAR), to prepare the healthcare enterprise for potential critical events. Also worked on expanding a variety of student financial assistance programs such as Pell Grant appropriation to the Supplemental Educational Opportunities Grant, increase to Federal Work-Study, increase to the Perkins Loan Program, and increase to the GAANN/Javits fellowships. Supported expansion of the Nursing Reinvestment Act funding health professions appropriations HR 2862 providing funding for Science, State, Justice and Commerce programs/ S. (not yet reported) providing funding for Commerce, Justice and Science programs worked on AAU’s advocacy for an increase in NASA Science, Aeronautics and Exploration activities; for the Office of Earth Science and an increase for the Office of Biological and Physical Research; specifically worked to obtain funding for a Nanobiotechnology Institute (through NASA); also supported through AAU advocacy increasing the NSF budget HR 3058 providing funding for Transportation, Treasury, HUD, Judiciary and the District of Columbia/S. (not yet reported) providing funding for Transportation, Treasury, Judiciary and HUD: Supported funding requests made for East Baltimore Development Inc. HR 4613/S 2559, “Department of Defense Appropriations Act, 2005”: worked through the AAU for continued growth in support for DOD Science, with particular emphasis on basic (6.1) as opposed to and applied (6.2) research; specifically addressed the need for a new Center of Excellence in Military Low Vision Research. Monitored: H. Con. Res. 95 the fiscal year 2006 Concurrent Resolution on the Budget with respect to: research funding at NIH, NSF, DOD, CDC and NASA and proposed reconciliation instructions for reductions in student aid and Medicare or Medicaid programs.

HR 3010/S (not yet reported), “Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2006”: worked on the following items: an increase to the National Institutes of Health budget; amendments to the House-reported bill to eliminate funding of certain NIH grants already approved through the peer review processes; the advocacy effort for increased funding for extramural facilities construction through the National Institutes of Health. Also supported funding request for Critical Event Preparedness and Response (CEPAR), to prepare the healthcare enterprise for potential critical events. Also worked on expanding a variety of student financial assistance programs such as Pell Grant appropriation to the Supplemental Educational Opportunities Grant, increase to Federal Work-Study, increase to the Perkins Loan Program, and increase to the GAANN/Javits fellowships. Supported expansion of the Nursing Reinvestment Act funding health professions appropriations HR 2862 providing funding for Science, State, Justice and Commerce programs/ S. (not yet reported) providing funding for Commerce, Justice and Science programs worked on AAU’s advocacy for an increase in NASA Science, Aeronautics and Exploration activities; for the Office of Earth Science and an increase for the Office of Biological and Physical Research; specifically worked to obtain funding for a Nanobiotechnology Institute (through NASA); also supported through AAU advocacy increasing the NSF budget HR 3058 providing funding for Transportation, Treasury, HUD, Judiciary and the District of Columbia/S. (not yet reported) providing funding for Transportation, Treasury, Judiciary and HUD: Supported funding requests made for East Baltimore Development Inc. HR 4613/S 2559, “Department of Defense Appropriations Act, 2005”: worked through the AAU for continued growth in support for DOD Science, with particular emphasis on basic (6.1) as opposed to and applied (6.2) research; specifically addressed the need for a new Center of Excellence in Military Low Vision Research. Monitored: H. Con. Res. 95 the fiscal year 2006 Concurrent Resolution on the Budget with respect to: research funding at NIH, NSF, DOD, CDC and NASA and proposed reconciliation instructions for reductions in student aid and Medicare or Medicaid programs.

Monitored: HR 3261, “Database and Collections of Information Misappropriation Act” HR 2517, “Piracy Deterrence and Education Act of 2003” HR 107, “Digital Media Consumers' Rights Act of 2003” S.2560, “Inducing Infringement of Copyrights Act of 2004” Patent legislation The CREATE Act

Monitored: HR 3261, “Database and Collections of Information Misappropriation Act” HR 2517, “Piracy Deterrence and Education Act of 2003” HR 107, “Digital Media Consumers' Rights Act of 2003” S.2560, “Inducing Infringement of Copyrights Act of 2004” Patent legislation The CREATE Act NIH proposal regarding public access to articles resulting from sponsored research

Monitored: HR 3261, “Database and Collections of Information Misappropriation Act” HR 2517, “Piracy Deterrence and Education Act of 2003” HR 107, “Digital Media Consumers' Rights Act of 2003” S.2560, “Inducing Infringement of Copyrights Act of 2004” Patent legislation The CREATE Act

Monitored: HR 3261, “Database and Collections of Information Misappropriation Act” HR 2517, “Piracy Deterrence and Education Act of 2003” HR 107, “Digital Media Consumers' Rights Act of 2003” S.2560, “Inducing Infringement of Copyrights Act of 2004” Patent legislation The CREATE Act NIH proposal regarding public access to articles resulting from sponsored research

Monitored: HR 4682, “Stem Cell Research Enhancement Act of 2004” HR 4812, “Stem Cell Discovery Through Diversity Act" S.303, “Human Cloning Ban and Stem Cell Research Protection Act of 2003” HR 4531, “Ronald Reagan Memorial Stem Cell Research Act of 2004” S.2533/HR 4595, "Ronald Reagan Alzheimer's Breakthrough Act of 2004" (also discussed this bill with members of MD Delegation) HR 3960, “Stem Cell Replenishment Act of 2004” HR 2852, “Stem Cell Act of 2003” S.1717, “Cord Blood Stem Cell Act of 2003” Worked with the Coalition for the Advancement of Medical research to track such issues. Requested that Maryland Congressional Delegation sign letter appealing to President Bush to expand policy concerning stem cell research. Wrote to NIH regarding position on a request to invoke march-in proceedings for patent rights on two pharmaceuticals.

Monitored: HR 4682, “Stem Cell Research Enhancement Act of 2004” HR 4812, “Stem Cell Discovery Through Diversity Act" S.303, “Human Cloning Ban and Stem Cell Research Protection Act of 2003” HR 4531, “Ronald Reagan Memorial Stem Cell Research Act of 2004” S.2533/HR 4595, "Ronald Reagan Alzheimer's Breakthrough Act of 2004" (also discussed this bill with members of MD Delegation) HR 3960, “Stem Cell Replenishment Act of 2004” HR 2852, “Stem Cell Act of 2003” S.1717, “Cord Blood Stem Cell Act of 2003” Worked with the Coalition for the Advancement of Medical research to track such issues. Requested that Maryland Congressional Delegation sign letter appealing to President Bush to expand policy concerning stem cell research. Wrote to NIH regarding position on a request to invoke march-in proceedings for patent rights on two pharmaceuticals.

Monitored: HR 3261, “Database and Collections of Information Misappropriation Act” HR 2517, “Piracy Deterrence and Education Act of 2003” HR 107, “Digital Media Consumers' Rights Act of 2003” S.2560, “Inducing Infringement of Copyrights Act of 2004” Patent legislation The CREATE Act

Monitored: HR 3261, “Database and Collections of Information Misappropriation Act” HR 2517, “Piracy Deterrence and Education Act of 2003” HR 107, “Digital Media Consumers' Rights Act of 2003” S.2560, “Inducing Infringement of Copyrights Act of 2004” Patent legislation The CREATE Act NIH proposal regarding public access to articles resulting from sponsored research

Monitored: HR 4682, “Stem Cell Research Enhancement Act of 2004” HR 4812, “Stem Cell Discovery Through Diversity Act" S.303, “Human Cloning Ban and Stem Cell Research Protection Act of 2003” HR 4531, “Ronald Reagan Memorial Stem Cell Research Act of 2004” S.2533/HR 4595, "Ronald Reagan Alzheimer's Breakthrough Act of 2004" (also discussed this bill with members of MD Delegation) HR 3960, “Stem Cell Replenishment Act of 2004” HR 2852, “Stem Cell Act of 2003” S.1717, “Cord Blood Stem Cell Act of 2003” Worked with the Coalition for the Advancement of Medical research to track such issues. Requested that Maryland Congressional Delegation sign letter appealing to President Bush to expand policy concerning stem cell research. Wrote to NIH regarding position on a request to invoke march-in proceedings for patent rights on two pharmaceuticals.

Monitored: HR 4682, “Stem Cell Research Enhancement Act of 2004” HR 4812, “Stem Cell Discovery Through Diversity Act" S.303, “Human Cloning Ban and Stem Cell Research Protection Act of 2003” HR 4531, “Ronald Reagan Memorial Stem Cell Research Act of 2004” S.2533/HR 4595, "Ronald Reagan Alzheimer's Breakthrough Act of 2004" (also discussed this bill with members of MD Delegation) HR 3960, “Stem Cell Replenishment Act of 2004” HR 2852, “Stem Cell Act of 2003” S.1717, “Cord Blood Stem Cell Act of 2003” Worked with the Coalition for the Advancement of Medical research to track such issues. Requested that Maryland Congressional Delegation sign letter appealing to President Bush to expand policy concerning stem cell research. Wrote to NIH regarding position on a request to invoke march-in proceedings for patent rights on two pharmaceuticals.

HR 5006/S 2810**HR 4818, “Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2005”: worked on the following items: an increase of 10 percent to the National Institutes of Health budget; potential Toomey-type amendments in the FY 2005 Labor, Health and Human Services and Education Appropriations bill, which stands to alter the funding of certain NIH grant review processes; the advocacy effort for increased funding for extramural facilities construction through the National Institutes of Health. Supported funding request of $1.5 million for “OR-1” a state-of-the-art operating suite for use in minimally invasive surgery. Also supported funding request for Critical Event Preparedness and Response (CEPAR), to prepare the healthcare enterprise for potential critical events. Worked on expanding a variety of student financial assistance programs such as Pell Grant appropriation to $14 billion, $115 million increase to the Supplemental Educational Opportunities Grant, $157 million increase to Federal Work-Study, $40.6 million increase to the Perkins Loan Program, and increase to the GAANN/Javits fellowships. Supported expansion of the Nursing Reinvestment Act funding health professions appropriations within Labor, HHS appropriations bill. HR 4118/S *HR 4818, Energy and Water Development Appropriations Act, 2005”: Discussed maintenance of research funding at the National Science Foundation and at the Department of Energy with particular emphasis in investing in basic research. HR 5041/S. 2825**HR 4818 “Department of Veterans Affairs and Housing and Urban Development, and Independent Agencies Appropriations Act, 2005”: worked on AAU’s advocacy for a $7.7 billion increase in NASA Science, Aeronautics and Exploration activities; $34 million additional for the Office of Earth Science and an increase of $39 million for the Office of Biological and Physical Research; specifically worked on continued funding for the Solar Probe which provides for the next mission at Johns Hopkins Applied Physics Laboratory and for $2 million for 8 FTE for NASA Contract Office at APL, Space Department; the NSF budget of $6.4 billion with particular support for the graduate programs like the Graduate Research Fellowship and support for funding areas to support the Nanotechnology Consortium in Maryland; continued support from EPA for the Center for Urban Asthma Studies and $250 thousand to conduct a review of the Baltimore region air quality data. Supported funding requests made for East Baltimore Development Inc., funding requests for emergency preparedness, and funding request for operating room equipment. HR 4567/S 2537, “Homeland Security Act, 2005”: urged appropriations for a Science and Technology Directorate and new funding for science and technology as well as university-based research within the Homeland Security area. Bioterrorism – Homeland Security Act: expressed concern over the flow of funds designated for improvements to the medical emergency preparedness and response system. HR 4613/S 2559, “Department of Defense Appropriations Act, 2005”: worked on continued growth in support for DOD Science, with particular emphasis on basic (6.1) and applied (6.2) research; the proposed “devolvement” of certain S&T programs and the transfer of the National Security Education Program to DOE. HR4818/S 2812, “Foreign Operations, Export Financing, and related programs Appropriation Act, 2005”: worked on report language in support of the Center for Public Health and Human Rights.

HR 4283 “College Access and Opportunity Act of 2004”, Worked collaboratively the university community positions on the Reauthorization of Higher Education Act. Visited offices of all ten members of the Maryland Delegation. Worked toward increased access to higher education for low-income students by strengthening support for grants and early intervention programs, particularly the Pell Grant program; increase in financial aid support for graduate education through GAANN, Javits and FLAS fellowship and grant programs; increased access to both undergraduate and graduate education by raising student loan borrowing limits. Communicated by letter to leadership in both House and Senate Committees regarding the omission of “experimental site” designations within the reauthorization bill. This program provides for more flexible means of calculating individual student aid packages; reducing the regulatory burden on universities; ensuring accountability of institutions through an accreditation system and provides a decentralized system of higher education accreditation. Monitored proposal from Department of Education to require individual student unit record reporting.

Kept Maryland Delegation apprised of concerns associated with the growing Medicare population and the pressures this presents for the healthcare system. Continued to appeal to CMS to adjust the Medicare Sustainable Growth Rate (formula) SGR. Met with HHS staff in the office of the Director for Medicare Services to discuss SGR and opportunities to design demo projects. Monitored the implementation of the Medicare Modernization Act. Tracking: HR 4903, "Medicare Advantage and Prescription Drug Accountability Act of 2004" S.2725, "Closing the Coverage Gap Act of 2004" S.2766, "Prescription Drug and Health Improvement Act of 2004" HR 4919, "Medicare Drug Card Guaranteed Savings Act" HR4898/S.2535, "Medicare Preventative Services Coverage Act of 2004" HR 4491, "Hobson amendment"

Kept Maryland Delegation apprised of concerns associated with the growing Medicare population and the pressures this presents for the healthcare system. Continued to appeal to CMS to adjust the Medicare Sustainable Growth Rate (formula) SGR. Monitored the implementation of the Medicare Modernization Act. Tracking: HR 4903, "Medicare Advantage and Prescription Drug Accountability Act of 2004" S.2725, "Closing the Coverage Gap Act of 2004" S.2766, "Prescription Drug and Health Improvement Act of 2004" HR 4919, "Medicare Drug Card Guaranteed Savings Act" HR4898/S.2535, "Medicare Preventative Services Coverage Act of 2004" HR 4491, "Hobson amendment"

Monitored: HR 4682, “Stem Cell Research Enhancement Act of 2004” HR 4812, “Stem Cell Discovery Through Diversity Act" S.303, “Human Cloning Ban and Stem Cell Research Protection Act of 2003” HR 4531, “Ronald Reagan Memorial Stem Cell Research Act of 2004” S.2533/HR 4595, "Ronald Reagan Alzheimer's Breakthrough Act of 2004" (also discussed this bill with members of MD Delegation) HR 3960, “Stem Cell Replenishment Act of 2004” HR 2852, “Stem Cell Act of 2003” S.1717, “Cord Blood Stem Cell Act of 2003” Worked with the Coalition for the Advancement of Medical research to track such issues. Requested that Maryland Congressional Delegation sign letter appealing to President Bush to expand policy concerning stem cell research. Wrote to NIH regarding position on a request to invoke march-in proceedings for patent rights on two pharmaceuticals.

Monitored: HR 4682, “Stem Cell Research Enhancement Act of 2004” HR 4812, “Stem Cell Discovery Through Diversity Act" S.303, “Human Cloning Ban and Stem Cell Research Protection Act of 2003” HR 4531, “Ronald Reagan Memorial Stem Cell Research Act of 2004” S.2533/HR 4595, "Ronald Reagan Alzheimer's Breakthrough Act of 2004" (also discussed this bill with members of MD Delegation) HR 3960, “Stem Cell Replenishment Act of 2004” HR 2852, “Stem Cell Act of 2003” S.1717, “Cord Blood Stem Cell Act of 2003” Worked with the Coalition for the Advancement of Medical research to track such issues. Requested that Maryland Congressional Delegation sign letter appealing to President Bush to expand policy concerning stem cell research. Wrote to NIH regarding position on a request to invoke march-in proceedings for patent rights on two pharmaceuticals.

Monitored: HR 4682, “Stem Cell Research Enhancement Act of 2004” HR 4812, “Stem Cell Discovery Through Diversity Act" S.303, “Human Cloning Ban and Stem Cell Research Protection Act of 2003” HR 4531, “Ronald Reagan Memorial Stem Cell Research Act of 2004” S.2533/HR 4595, "Ronald Reagan Alzheimer's Breakthrough Act of 2004" (also discussed this bill with members of MD Delegation) HR 3960, “Stem Cell Replenishment Act of 2004” HR 2852, “Stem Cell Act of 2003” S.1717, “Cord Blood Stem Cell Act of 2003” Worked with the Coalition for the Advancement of Medical research to track such issues. Requested that Maryland Congressional Delegation sign letter appealing to President Bush to expand policy concerning stem cell research. Wrote to NIH regarding position on a request to invoke march-in proceedings for patent rights on two pharmaceuticals.

Monitored: HR 4682, “Stem Cell Research Enhancement Act of 2004” HR 4812, “Stem Cell Discovery Through Diversity Act" S.303, “Human Cloning Ban and Stem Cell Research Protection Act of 2003” HR 4531, “Ronald Reagan Memorial Stem Cell Research Act of 2004” S.2533/HR 4595, "Ronald Reagan Alzheimer's Breakthrough Act of 2004" (also discussed this bill with members of MD Delegation) HR 3960, “Stem Cell Replenishment Act of 2004” HR 2852, “Stem Cell Act of 2003” S.1717, “Cord Blood Stem Cell Act of 2003” Worked with the Coalition for the Advancement of Medical research to track such issues. Requested that Maryland Congressional Delegation sign letter appealing to President Bush to expand policy concerning stem cell research. Wrote to NIH regarding position on a request to invoke march-in proceedings for patent rights on two pharmaceuticals.

Monitored: HR 4682, “Stem Cell Research Enhancement Act of 2004” HR 4812, “Stem Cell Discovery Through Diversity Act" S.303, “Human Cloning Ban and Stem Cell Research Protection Act of 2003” HR 4531, “Ronald Reagan Memorial Stem Cell Research Act of 2004” S.2533/HR 4595, "Ronald Reagan Alzheimer's Breakthrough Act of 2004" (also discussed this bill with members of MD Delegation) HR 3960, “Stem Cell Replenishment Act of 2004” HR 2852, “Stem Cell Act of 2003” S.1717, “Cord Blood Stem Cell Act of 2003” Worked with the Coalition for the Advancement of Medical research to track such issues. Requested that Maryland Congressional Delegation sign letter appealing to President Bush to expand policy concerning stem cell research. Wrote to NIH regarding position on a request to invoke march-in proceedings for patent rights on two pharmaceuticals.

Monitored: HR 4682, “Stem Cell Research Enhancement Act of 2004” HR 4812, “Stem Cell Discovery Through Diversity Act" S.303, “Human Cloning Ban and Stem Cell Research Protection Act of 2003” HR 4531, “Ronald Reagan Memorial Stem Cell Research Act of 2004” S.2533/HR 4595, "Ronald Reagan Alzheimer's Breakthrough Act of 2004" (also discussed this bill with members of MD Delegation) HR 3960, “Stem Cell Replenishment Act of 2004” HR 2852, “Stem Cell Act of 2003” S.1717, “Cord Blood Stem Cell Act of 2003” Worked with the Coalition for the Advancement of Medical research to track such issues. Requested that Maryland Congressional Delegation sign letter appealing to President Bush to expand policy concerning stem cell research. Wrote to NIH regarding position on a request to invoke march-in proceedings for patent rights on two pharmaceuticals.

Monitored: HR 4682, “Stem Cell Research Enhancement Act of 2004” HR 4812, “Stem Cell Discovery Through Diversity Act" S.303, “Human Cloning Ban and Stem Cell Research Protection Act of 2003” HR 4531, “Ronald Reagan Memorial Stem Cell Research Act of 2004” S.2533/HR 4595, "Ronald Reagan Alzheimer's Breakthrough Act of 2004" (also discussed this bill with members of MD Delegation) HR 3960, “Stem Cell Replenishment Act of 2004” HR 2852, “Stem Cell Act of 2003” S.1717, “Cord Blood Stem Cell Act of 2003” Worked with the Coalition for the Advancement of Medical research to track such issues. Requested that Maryland Congressional Delegation sign letter appealing to President Bush to expand policy concerning stem cell research. Wrote to NIH regarding position on a request to invoke march-in proceedings for patent rights on two pharmaceuticals.

Monitored: HR 4682, “Stem Cell Research Enhancement Act of 2004” HR 4812, “Stem Cell Discovery Through Diversity Act" S.303, “Human Cloning Ban and Stem Cell Research Protection Act of 2003” HR 4531, “Ronald Reagan Memorial Stem Cell Research Act of 2004” S.2533/HR 4595, "Ronald Reagan Alzheimer's Breakthrough Act of 2004" (also discussed this bill with members of MD Delegation) HR 3960, “Stem Cell Replenishment Act of 2004” HR 2852, “Stem Cell Act of 2003” S.1717, “Cord Blood Stem Cell Act of 2003” Worked with the Coalition for the Advancement of Medical research to track such issues. Requested that Maryland Congressional Delegation sign letter appealing to President Bush to expand policy concerning stem cell research. Wrote to NIH regarding position on a request to invoke march-in proceedings for patent rights on two pharmaceuticals.

Kept Maryland Delegation apprised of concerns associated with the growing Medicare population and the pressures this presents for the healthcare system. Continued to appeal to CMS to adjust the Medicare Sustainable Growth Rate (formula) SGR. Met with HHS staff in the office of the Director for Medicare Services to discuss SGR and opportunities to design demo projects. Monitored the implementation of the Medicare Modernization Act. Tracking: HR 4903, "Medicare Advantage and Prescription Drug Accountability Act of 2004" S.2725, "Closing the Coverage Gap Act of 2004" S.2766, "Prescription Drug and Health Improvement Act of 2004" HR 4919, "Medicare Drug Card Guaranteed Savings Act" HR4898/S.2535, "Medicare Preventative Services Coverage Act of 2004" HR 4491, "Hobson amendment"

Kept Maryland Delegation apprised of concerns associated with the growing Medicare population and the pressures this presents for the healthcare system. Continued to appeal to CMS to adjust the Medicare Sustainable Growth Rate (formula) SGR. Monitored the implementation of the Medicare Modernization Act. Tracking: HR 4903, "Medicare Advantage and Prescription Drug Accountability Act of 2004" S.2725, "Closing the Coverage Gap Act of 2004" S.2766, "Prescription Drug and Health Improvement Act of 2004" HR 4919, "Medicare Drug Card Guaranteed Savings Act" HR4898/S.2535, "Medicare Preventative Services Coverage Act of 2004" HR 4491, "Hobson amendment"

Kept Maryland Delegation apprised of concerns associated with the growing Medicare population and the pressures this presents for the healthcare system. Continued to appeal to CMS to adjust the Medicare Sustainable Growth Rate (formula) SGR. Monitored the implementation of the Medicare Modernization Act. Tracking: HR 4903, "Medicare Advantage and Prescription Drug Accountability Act of 2004" S.2725, "Closing the Coverage Gap Act of 2004" S.2766, "Prescription Drug and Health Improvement Act of 2004" HR 4919, "Medicare Drug Card Guaranteed Savings Act" HR4898/S.2535, "Medicare Preventative Services Coverage Act of 2004" HR 4491, "Hobson amendment"

Kept Maryland Delegation apprised of concerns associated with the growing Medicare population and the pressures this presents for the healthcare system. Continued to appeal to CMS to adjust the Medicare Sustainable Growth Rate (formula) SGR. Met with HHS staff in the office of the Director for Medicare Services to discuss SGR and opportunities to design demo projects. Monitored the implementation of the Medicare Modernization Act. Tracking: HR 4903, "Medicare Advantage and Prescription Drug Accountability Act of 2004" S.2725, "Closing the Coverage Gap Act of 2004" S.2766, "Prescription Drug and Health Improvement Act of 2004" HR 4919, "Medicare Drug Card Guaranteed Savings Act" HR4898/S.2535, "Medicare Preventative Services Coverage Act of 2004" HR 4491, "Hobson amendment"

Kept Maryland Delegation apprised of concerns associated with the growing Medicare population and the pressures this presents for the healthcare system. Continued to appeal to CMS to adjust the Medicare Sustainable Growth Rate (formula) SGR. Monitored the implementation of the Medicare Modernization Act. Tracking: HR 4903, "Medicare Advantage and Prescription Drug Accountability Act of 2004" S.2725, "Closing the Coverage Gap Act of 2004" S.2766, "Prescription Drug and Health Improvement Act of 2004" HR 4919, "Medicare Drug Card Guaranteed Savings Act" HR4898/S.2535, "Medicare Preventative Services Coverage Act of 2004" HR 4491, "Hobson amendment"

Kept Maryland Delegation apprised of concerns associated with the growing Medicare population and the pressures this presents for the healthcare system. Continued to appeal to CMS to adjust the Medicare Sustainable Growth Rate (formula) SGR. Met with HHS staff in the office of the Director for Medicare Services to discuss SGR and opportunities to design demo projects. Monitored the implementation of the Medicare Modernization Act. Tracking: HR 4903, "Medicare Advantage and Prescription Drug Accountability Act of 2004" S.2725, "Closing the Coverage Gap Act of 2004" S.2766, "Prescription Drug and Health Improvement Act of 2004" HR 4919, "Medicare Drug Card Guaranteed Savings Act" HR4898/S.2535, "Medicare Preventative Services Coverage Act of 2004" HR 4491, "Hobson amendment"

Communicated several issues concerning academic health centers to the Secretary of Health and Human Services and his office including: implementation of HIPAA rules, the development of regional electronic patient record systems, and concerns about physician reimbursement rates, medical liability, patient safety, bioterrorism and facilities and administration support. Worked in cooperation with AAMC and AHA to appeal to CMS to consider adjustments to the Medicare sustainable growth rate formula. Johns Hopkins is part of the Maryland/DC Collaborative for Healthcare Information Technology (formerly Maryland/DC E-Health Initiative) to develop and implement a regional electronic patient record system. Continue to keep all members of the Maryland Delegation apprised of the Collaborative’s progress. Monitored HR 663 and S.720, both Patient Safety and Quality Improvement Acts that create voluntary systems for tracking medical errors and promise confidentiality to hospitals and doctors; monitored HR 5, “Help Efficient, Accessible, Low-Cost, Timely Healthcare (HEALTH) Act of 2003,” that sets a cap on medical liability; and monitored any Congressional activity that may result from recent court decisions regarding patent infringement claims. Advocated funding and monitored NIH and NSF budgets along with the Association of American Universities (AAU) and Association of American Medical Colleges (AAMC)-see budget section. Monitored S.15, “Project BioShield Act of 2004” Monitored legislation and raised awareness of potential Toomey–type amendments, which would potentially alter the funding of specific NIH-sponsored research projects that had undergone the established peer review processes. Continue to monitor legislative efforts on patient safety, physician reimbursement rates, quality improvement and medical liability.

Communicated several issues concerning academic health centers to the Secretary of Health and Human Services and his office including: implementation of HIPAA rules, the development of regional electronic patient record systems, and concerns about physician reimbursement rates, medical liability, patient safety, bioterrorism and facilities and administration support. Worked in cooperation with AAMC and AHA to appeal to CMS to consider adjustments to the Medicare sustainable growth rate formula. Johns Hopkins is part of the Maryland/DC Collaborative for Healthcare Information Technology (formerly Maryland/DC E-Health Initiative) to develop and implement a regional electronic patient record system. Continue to keep all members of the Maryland Delegation apprised of the Collaborative’s progress. Monitored HR 663 and S.720, both Patient Safety and Quality Improvement Acts that create voluntary systems for tracking medical errors and promise confidentiality to hospitals and doctors; monitored HR 5, “Help Efficient, Accessible, Low-Cost, Timely Healthcare (HEALTH) Act of 2003,” that sets a cap on medical liability; and monitored any Congressional activity that may result from recent court decisions regarding patent infringement claims. Advocated funding and monitored NIH and NSF budgets along with the Association of American Universities (AAU) and Association of American Medical Colleges (AAMC)-see budget section. Monitored S.15, “Project BioShield Act of 2004” Monitored legislation and raised awareness of potential Toomey–type amendments, which would potentially alter the funding of specific NIH-sponsored research projects that had undergone the established peer review processes. Continue to monitor legislative efforts on patient safety, physician reimbursement rates, quality improvement and medical liability. Monitored the shortage of flu vaccine and attempts to obtain vaccine from Canada. Monitored NIH and Congressional review of the use of federal funds for HIV research in Uganda.

HR 5041/S 2825*HR 4818, Supported the requests on behalf of the East Baltimore Development Inc. for the support in FY 2005 HUD/VA Appropriations bill for redevelopment activities including large-scale property acquisition and demolition; economic development and job creation as well as re-development of housing anchored by a biotech facility located near Johns Hopkins Hospital.

HR 5006/S 2810**HR 4818, “Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2005”: worked on the following items: an increase of 10 percent to the National Institutes of Health budget; potential Toomey-type amendments in the FY 2005 Labor, Health and Human Services and Education Appropriations bill, which stands to alter the funding of certain NIH grant review processes; the advocacy effort for increased funding for extramural facilities construction through the National Institutes of Health. Supported funding request of $1.5 million for “OR-1” a state-of-the-art operating suite for use in minimally invasive surgery. Also supported funding request for Critical Event Preparedness and Response (CEPAR), to prepare the healthcare enterprise for potential critical events. Worked on expanding a variety of student financial assistance programs such as Pell Grant appropriation to $14 billion, $115 million increase to the Supplemental Educational Opportunities Grant, $157 million increase to Federal Work-Study, $40.6 million increase to the Perkins Loan Program, and increase to the GAANN/Javits fellowships. Supported expansion of the Nursing Reinvestment Act funding health professions appropriations within Labor, HHS appropriations bill. HR 4118/S *HR 4818, Energy and Water Development Appropriations Act, 2005”: Discussed maintenance of research funding at the National Science Foundation and at the Department of Energy with particular emphasis in investing in basic research. HR 5041/S. 2825**HR 4818 “Department of Veterans Affairs and Housing and Urban Development, and Independent Agencies Appropriations Act, 2005”: worked on AAU’s advocacy for a $7.7 billion increase in NASA Science, Aeronautics and Exploration activities; $34 million additional for the Office of Earth Science and an increase of $39 million for the Office of Biological and Physical Research; specifically worked on continued funding for the Solar Probe which provides for the next mission at Johns Hopkins Applied Physics Laboratory and for $2 million for 8 FTE for NASA Contract Office at APL, Space Department; the NSF budget of $6.4 billion with particular support for the graduate programs like the Graduate Research Fellowship and support for funding areas to support the Nanotechnology Consortium in Maryland; continued support from EPA for the Center for Urban Asthma Studies and $250 thousand to conduct a review of the Baltimore region air quality data. Supported funding requests made for East Baltimore Development Inc., funding requests for emergency preparedness, and funding request for operating room equipment. HR 4567/S 2537, “Homeland Security Act, 2005”: urged appropriations for a Science and Technology Directorate and new funding for science and technology as well as university-based research within the Homeland Security area. Bioterrorism – Homeland Security Act: expressed concern over the flow of funds designated for improvements to the medical emergency preparedness and response system. HR 4613/S 2559, “Department of Defense Appropriations Act, 2005”: worked on continued growth in support for DOD Science, with particular emphasis on basic (6.1) and applied (6.2) research; the proposed “devolvement” of certain S&T programs and the transfer of the National Security Education Program to DOE. HR4818/S 2812, “Foreign Operations, Export Financing, and related programs Appropriation Act, 2005”: worked on report language in support of the Center for Public Health and Human Rights.

Communicated several issues concerning academic health centers to the Secretary of Health and Human Services and his office including: implementation of HIPAA rules, the development of regional electronic patient record systems, and concerns about physician reimbursement rates, medical liability, patient safety, bioterrorism and facilities and administration support. Worked in cooperation with AAMC and AHA to appeal to CMS to consider adjustments to the Medicare sustainable growth rate formula. Johns Hopkins is part of the Maryland/DC Collaborative for Healthcare Information Technology (formerly Maryland/DC E-Health Initiative) to develop and implement a regional electronic patient record system. Continue to keep all members of the Maryland Delegation apprised of the Collaborative’s progress. Monitored HR 663 and S.720, both Patient Safety and Quality Improvement Acts that create voluntary systems for tracking medical errors and promise confidentiality to hospitals and doctors; monitored HR 5, “Help Efficient, Accessible, Low-Cost, Timely Healthcare (HEALTH) Act of 2003,” that sets a cap on medical liability; and monitored any Congressional activity that may result from recent court decisions regarding patent infringement claims. Advocated funding and monitored NIH and NSF budgets along with the Association of American Universities (AAU) and Association of American Medical Colleges (AAMC)-see budget section. Monitored S.15, “Project BioShield Act of 2004” Monitored legislation and raised awareness of potential Toomey–type amendments, which would potentially alter the funding of specific NIH-sponsored research projects that had undergone the established peer review processes. Continue to monitor legislative efforts on patient safety, physician reimbursement rates, quality improvement and medical liability. Monitored the shortage of flu vaccine and attempts to obtain vaccine from Canada. Monitored NIH and Congressional review of the use of federal funds for HIV research in Uganda.

Communicated several issues concerning academic health centers to the Secretary of Health and Human Services and his office including: implementation of HIPAA rules, the development of regional electronic patient record systems, and concerns about physician reimbursement rates, medical liability, patient safety, bioterrorism and facilities and administration support. Worked in cooperation with AAMC and AHA to appeal to CMS to consider adjustments to the Medicare sustainable growth rate formula. Johns Hopkins is part of the Maryland/DC Collaborative for Healthcare Information Technology (formerly Maryland/DC E-Health Initiative) to develop and implement a regional electronic patient record system. Continue to keep all members of the Maryland Delegation apprised of the Collaborative’s progress. Monitored HR 663 and S.720, both Patient Safety and Quality Improvement Acts that create voluntary systems for tracking medical errors and promise confidentiality to hospitals and doctors; monitored HR 5, “Help Efficient, Accessible, Low-Cost, Timely Healthcare (HEALTH) Act of 2003,” that sets a cap on medical liability; and monitored any Congressional activity that may result from recent court decisions regarding patent infringement claims. Advocated funding and monitored NIH and NSF budgets along with the Association of American Universities (AAU) and Association of American Medical Colleges (AAMC)-see budget section. Monitored S.15, “Project BioShield Act of 2004” Monitored legislation and raised awareness of potential Toomey–type amendments, which would potentially alter the funding of specific NIH-sponsored research projects that had undergone the established peer review processes. Continue to monitor legislative efforts on patient safety, physician reimbursement rates, quality improvement and medical liability.

Communicated several issues concerning academic health centers to the Secretary of Health and Human Services and his office including: implementation of HIPAA rules, the development of regional electronic patient record systems, and concerns about physician reimbursement rates, medical liability, patient safety, bioterrorism and facilities and administration support. Worked in cooperation with AAMC and AHA to appeal to CMS to consider adjustments to the Medicare sustainable growth rate formula. Johns Hopkins is part of the Maryland/DC Collaborative for Healthcare Information Technology (formerly Maryland/DC E-Health Initiative) to develop and implement a regional electronic patient record system. Continue to keep all members of the Maryland Delegation apprised of the Collaborative’s progress. Monitored HR 663 and S.720, both Patient Safety and Quality Improvement Acts that create voluntary systems for tracking medical errors and promise confidentiality to hospitals and doctors; monitored HR 5, “Help Efficient, Accessible, Low-Cost, Timely Healthcare (HEALTH) Act of 2003,” that sets a cap on medical liability; and monitored any Congressional activity that may result from recent court decisions regarding patent infringement claims. Advocated funding and monitored NIH and NSF budgets along with the Association of American Universities (AAU) and Association of American Medical Colleges (AAMC)-see budget section. Monitored S.15, “Project BioShield Act of 2004” Monitored legislation and raised awareness of potential Toomey–type amendments, which would potentially alter the funding of specific NIH-sponsored research projects that had undergone the established peer review processes. Continue to monitor legislative efforts on patient safety, physician reimbursement rates, quality improvement and medical liability. Monitored the shortage of flu vaccine and attempts to obtain vaccine from Canada. Monitored NIH and Congressional review of the use of federal funds for HIV research in Uganda.

Communicated several issues concerning academic health centers to the Secretary of Health and Human Services and his office including: implementation of HIPAA rules, the development of regional electronic patient record systems, and concerns about physician reimbursement rates, medical liability, patient safety, bioterrorism and facilities and administration support. Worked in cooperation with AAMC and AHA to appeal to CMS to consider adjustments to the Medicare sustainable growth rate formula. Johns Hopkins is part of the Maryland/DC Collaborative for Healthcare Information Technology (formerly Maryland/DC E-Health Initiative) to develop and implement a regional electronic patient record system. Continue to keep all members of the Maryland Delegation apprised of the Collaborative’s progress. Monitored HR 663 and S.720, both Patient Safety and Quality Improvement Acts that create voluntary systems for tracking medical errors and promise confidentiality to hospitals and doctors; monitored HR 5, “Help Efficient, Accessible, Low-Cost, Timely Healthcare (HEALTH) Act of 2003,” that sets a cap on medical liability; and monitored any Congressional activity that may result from recent court decisions regarding patent infringement claims. Advocated funding and monitored NIH and NSF budgets along with the Association of American Universities (AAU) and Association of American Medical Colleges (AAMC)-see budget section. Monitored S.15, “Project BioShield Act of 2004” Monitored legislation and raised awareness of potential Toomey–type amendments, which would potentially alter the funding of specific NIH-sponsored research projects that had undergone the established peer review processes. Continue to monitor legislative efforts on patient safety, physician reimbursement rates, quality improvement and medical liability.

Monitored: HR 4682, “Stem Cell Research Enhancement Act of 2004” HR 4812, “Stem Cell Discovery Through Diversity Act" S.303, “Human Cloning Ban and Stem Cell Research Protection Act of 2003” HR 4531, “Ronald Reagan Memorial Stem Cell Research Act of 2004” S.2533/HR 4595, "Ronald Reagan Alzheimer's Breakthrough Act of 2004" (also discussed this bill with members of MD Delegation) HR 3960, “Stem Cell Replenishment Act of 2004” HR 2852, “Stem Cell Act of 2003” S.1717, “Cord Blood Stem Cell Act of 2003” Worked with the Coalition for the Advancement of Medical research to track such issues. Requested that Maryland Congressional Delegation sign letter appealing to President Bush to expand policy concerning stem cell research. Wrote to NIH regarding position on a request to invoke march-in proceedings for patent rights on two pharmaceuticals.

Monitored: HR 4682, “Stem Cell Research Enhancement Act of 2004” HR 4812, “Stem Cell Discovery Through Diversity Act" S.303, “Human Cloning Ban and Stem Cell Research Protection Act of 2003” HR 4531, “Ronald Reagan Memorial Stem Cell Research Act of 2004” S.2533/HR 4595, "Ronald Reagan Alzheimer's Breakthrough Act of 2004" (also discussed this bill with members of MD Delegation) HR 3960, “Stem Cell Replenishment Act of 2004” HR 2852, “Stem Cell Act of 2003” S.1717, “Cord Blood Stem Cell Act of 2003” Worked with the Coalition for the Advancement of Medical research to track such issues. Requested that Maryland Congressional Delegation sign letter appealing to President Bush to expand policy concerning stem cell research. Wrote to NIH regarding position on a request to invoke march-in proceedings for patent rights on two pharmaceuticals.

Monitored: HR 4682, “Stem Cell Research Enhancement Act of 2004” HR 4812, “Stem Cell Discovery Through Diversity Act" S.303, “Human Cloning Ban and Stem Cell Research Protection Act of 2003” HR 4531, “Ronald Reagan Memorial Stem Cell Research Act of 2004” S.2533/HR 4595, "Ronald Reagan Alzheimer's Breakthrough Act of 2004" (also discussed this bill with members of MD Delegation) HR 3960, “Stem Cell Replenishment Act of 2004” HR 2852, “Stem Cell Act of 2003” S.1717, “Cord Blood Stem Cell Act of 2003” Worked with the Coalition for the Advancement of Medical research to track such issues. Requested that Maryland Congressional Delegation sign letter appealing to President Bush to expand policy concerning stem cell research. Wrote to NIH regarding position on a request to invoke march-in proceedings for patent rights on two pharmaceuticals.

Monitored: HR 4682, “Stem Cell Research Enhancement Act of 2004” HR 4812, “Stem Cell Discovery Through Diversity Act" S.303, “Human Cloning Ban and Stem Cell Research Protection Act of 2003” HR 4531, “Ronald Reagan Memorial Stem Cell Research Act of 2004” S.2533/HR 4595, "Ronald Reagan Alzheimer's Breakthrough Act of 2004" (also discussed this bill with members of MD Delegation) HR 3960, “Stem Cell Replenishment Act of 2004” HR 2852, “Stem Cell Act of 2003” S.1717, “Cord Blood Stem Cell Act of 2003” Worked with the Coalition for the Advancement of Medical research to track such issues. Requested that Maryland Congressional Delegation sign letter appealing to President Bush to expand policy concerning stem cell research. Wrote to NIH regarding position on a request to invoke march-in proceedings for patent rights on two pharmaceuticals.

Kept Maryland Delegation apprised of concerns associated with the growing Medicare population and the pressures this presents for the healthcare system. Continued to appeal to CMS to adjust the Medicare Sustainable Growth Rate (formula) SGR. Monitored the implementation of the Medicare Modernization Act. Tracking: HR 4903, "Medicare Advantage and Prescription Drug Accountability Act of 2004" S.2725, "Closing the Coverage Gap Act of 2004" S.2766, "Prescription Drug and Health Improvement Act of 2004" HR 4919, "Medicare Drug Card Guaranteed Savings Act" HR4898/S.2535, "Medicare Preventative Services Coverage Act of 2004" HR 4491, "Hobson amendment"

Kept Maryland Delegation apprised of concerns associated with the growing Medicare population and the pressures this presents for the healthcare system. Continued to appeal to CMS to adjust the Medicare Sustainable Growth Rate (formula) SGR. Met with HHS staff in the office of the Director for Medicare Services to discuss SGR and opportunities to design demo projects. Monitored the implementation of the Medicare Modernization Act. Tracking: HR 4903, "Medicare Advantage and Prescription Drug Accountability Act of 2004" S.2725, "Closing the Coverage Gap Act of 2004" S.2766, "Prescription Drug and Health Improvement Act of 2004" HR 4919, "Medicare Drug Card Guaranteed Savings Act" HR4898/S.2535, "Medicare Preventative Services Coverage Act of 2004" HR 4491, "Hobson amendment"

“Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2005”: worked on the following items: the Ad Hoc Group for Medical Research Funding, AAMC and AAU recommendations for an increase of 10 percent to the National Institutes of Health budget; potential Toomey-type amendments in the FY 2005 Labor, Health and Human Services and Education Appropriations bill, which stands to alter the funding of certain NIH grant review processes; the advocacy effort of AAU for increased funding for extramural facilities construction through the National Institutes of Health. Worked on expanding a variety of student financial assistance programs such as Pell Grant appropriation to $14 billion, $115 million increase to the Supplemental Educational Opportunities Grant, $157 million increase to Federal Work-Study, $40.6 million increase to the Perkins Loan Program, and increase to the GAANN/Javits fellowships. Supported expansion of the Nursing Reinvestment Act funding health professions appropriations within Labor, HHS appropriations bill. Worked on increased allotment for American Schools and Hospitals Abroad programs within the international programs section of the budget. Discussed maintenance of research funding at the National Science Foundation and at the Department of Energy (HR 4818/ S. draft, “Energy and Water Development Appropriations Act, 2005”) with particular emphasis in investing in basic research. “Department of Veterans Affairs and Housing and Urban Development, and Independent Agencies Appropriations Act, 2005”: worked on AAU’s advocacy for a $7.7 billion increase in NASA Science, Aeronautics and Exploration activities; $34 million additional for the Office of Earth Science and an increase of $39 million for the Office of Biological and Physical Research; specifically worked on continued funding for the Solar Probe which provides for the next mission at Johns Hopkins Applied Physics Laboratory, Space Department; the NSF budget of $6.4 billion with particular support for the graduate programs like the Graduate Research Fellowship and support for funding areas to support the Nanotechnology Consortium in Maryland; continued support from EPA for the Center for Urban Asthma Studies and $250 thousand to conduct a review of the Baltimore region air quality data. Supported funding requests made for East Baltimore Development Inc., funding requests for emergency preparedness, and funding request for operating room equipment. HR 4567/S.2537, “Homeland Security Act, 2005”: urged appropriations for a Science and Technology Directorate and new funding for science and technology as well as university-based research within the Homeland Security area. Bioterrorism – Homeland Security Act: expressed concern over the flow of funds designated for improvements to the medical emergency preparedness and response system. HR 4613/S.2559, “Department of Defense Appropriations Act, 2005”: worked on continued growth in support for DOD Science, with particular emphasis on basic (6.1) and applied (6.2) research; the proposed “devolvement” of certain S&T programs and the transfer of the National Security Education Program to DOE.

HR 5006/S 2810**HR 4818, “Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2005”: worked on the following items: an increase of 10 percent to the National Institutes of Health budget; potential Toomey-type amendments in the FY 2005 Labor, Health and Human Services and Education Appropriations bill, which stands to alter the funding of certain NIH grant review processes; the advocacy effort for increased funding for extramural facilities construction through the National Institutes of Health. Supported funding request of $1.5 million for “OR-1” a state-of-the-art operating suite for use in minimally invasive surgery. Also supported funding request for Critical Event Preparedness and Response (CEPAR), to prepare the healthcare enterprise for potential critical events. Worked on expanding a variety of student financial assistance programs such as Pell Grant appropriation to $14 billion, $115 million increase to the Supplemental Educational Opportunities Grant, $157 million increase to Federal Work-Study, $40.6 million increase to the Perkins Loan Program, and increase to the GAANN/Javits fellowships. Supported expansion of the Nursing Reinvestment Act funding health professions appropriations within Labor, HHS appropriations bill. HR 4118/S *HR 4818, Energy and Water Development Appropriations Act, 2005”: Discussed maintenance of research funding at the National Science Foundation and at the Department of Energy with particular emphasis in investing in basic research. HR 5041/S. 2825**HR 4818 “Department of Veterans Affairs and Housing and Urban Development, and Independent Agencies Appropriations Act, 2005”: worked on AAU’s advocacy for a $7.7 billion increase in NASA Science, Aeronautics and Exploration activities; $34 million additional for the Office of Earth Science and an increase of $39 million for the Office of Biological and Physical Research; specifically worked on continued funding for the Solar Probe which provides for the next mission at Johns Hopkins Applied Physics Laboratory and for $2 million for 8 FTE for NASA Contract Office at APL, Space Department; the NSF budget of $6.4 billion with particular support for the graduate programs like the Graduate Research Fellowship and support for funding areas to support the Nanotechnology Consortium in Maryland; continued support from EPA for the Center for Urban Asthma Studies and $250 thousand to conduct a review of the Baltimore region air quality data. Supported funding requests made for East Baltimore Development Inc., funding requests for emergency preparedness, and funding request for operating room equipment. HR 4567/S 2537, “Homeland Security Act, 2005”: urged appropriations for a Science and Technology Directorate and new funding for science and technology as well as university-based research within the Homeland Security area. Bioterrorism – Homeland Security Act: expressed concern over the flow of funds designated for improvements to the medical emergency preparedness and response system. HR 4613/S 2559, “Department of Defense Appropriations Act, 2005”: worked on continued growth in support for DOD Science, with particular emphasis on basic (6.1) and applied (6.2) research; the proposed “devolvement” of certain S&T programs and the transfer of the National Security Education Program to DOE. HR4818/S 2812, “Foreign Operations, Export Financing, and related programs Appropriation Act, 2005”: worked on report language in support of the Center for Public Health and Human Rights.

HR 5006/S 2810**HR 4818, “Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2005”: worked on the following items: an increase of 10 percent to the National Institutes of Health budget; potential Toomey-type amendments in the FY 2005 Labor, Health and Human Services and Education Appropriations bill, which stands to alter the funding of certain NIH grant review processes; the advocacy effort for increased funding for extramural facilities construction through the National Institutes of Health. Supported funding request of $1.5 million for “OR-1” a state-of-the-art operating suite for use in minimally invasive surgery. Also supported funding request for Critical Event Preparedness and Response (CEPAR), to prepare the healthcare enterprise for potential critical events. Worked on expanding a variety of student financial assistance programs such as Pell Grant appropriation to $14 billion, $115 million increase to the Supplemental Educational Opportunities Grant, $157 million increase to Federal Work-Study, $40.6 million increase to the Perkins Loan Program, and increase to the GAANN/Javits fellowships. Supported expansion of the Nursing Reinvestment Act funding health professions appropriations within Labor, HHS appropriations bill. HR 4118/S *HR 4818, Energy and Water Development Appropriations Act, 2005”: Discussed maintenance of research funding at the National Science Foundation and at the Department of Energy with particular emphasis in investing in basic research. HR 5041/S. 2825**HR 4818 “Department of Veterans Affairs and Housing and Urban Development, and Independent Agencies Appropriations Act, 2005”: worked on AAU’s advocacy for a $7.7 billion increase in NASA Science, Aeronautics and Exploration activities; $34 million additional for the Office of Earth Science and an increase of $39 million for the Office of Biological and Physical Research; specifically worked on continued funding for the Solar Probe which provides for the next mission at Johns Hopkins Applied Physics Laboratory and for $2 million for 8 FTE for NASA Contract Office at APL, Space Department; the NSF budget of $6.4 billion with particular support for the graduate programs like the Graduate Research Fellowship and support for funding areas to support the Nanotechnology Consortium in Maryland; continued support from EPA for the Center for Urban Asthma Studies and $250 thousand to conduct a review of the Baltimore region air quality data. Supported funding requests made for East Baltimore Development Inc., funding requests for emergency preparedness, and funding request for operating room equipment. HR 4567/S 2537, “Homeland Security Act, 2005”: urged appropriations for a Science and Technology Directorate and new funding for science and technology as well as university-based research within the Homeland Security area. Bioterrorism – Homeland Security Act: expressed concern over the flow of funds designated for improvements to the medical emergency preparedness and response system. HR 4613/S 2559, “Department of Defense Appropriations Act, 2005”: worked on continued growth in support for DOD Science, with particular emphasis on basic (6.1) and applied (6.2) research; the proposed “devolvement” of certain S&T programs and the transfer of the National Security Education Program to DOE. HR4818/S 2812, “Foreign Operations, Export Financing, and related programs Appropriation Act, 2005”: worked on report language in support of the Center for Public Health and Human Rights.

“Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2005”: worked on the following items: the Ad Hoc Group for Medical Research Funding, AAMC and AAU recommendations for an increase of 10 percent to the National Institutes of Health budget; potential Toomey-type amendments in the FY 2005 Labor, Health and Human Services and Education Appropriations bill, which stands to alter the funding of certain NIH grant review processes; the advocacy effort of AAU for increased funding for extramural facilities construction through the National Institutes of Health. Worked on expanding a variety of student financial assistance programs such as Pell Grant appropriation to $14 billion, $115 million increase to the Supplemental Educational Opportunities Grant, $157 million increase to Federal Work-Study, $40.6 million increase to the Perkins Loan Program, and increase to the GAANN/Javits fellowships. Supported expansion of the Nursing Reinvestment Act funding health professions appropriations within Labor, HHS appropriations bill. Worked on increased allotment for American Schools and Hospitals Abroad programs within the international programs section of the budget. Discussed maintenance of research funding at the National Science Foundation and at the Department of Energy (HR 4818/ S. draft, “Energy and Water Development Appropriations Act, 2005”) with particular emphasis in investing in basic research. “Department of Veterans Affairs and Housing and Urban Development, and Independent Agencies Appropriations Act, 2005”: worked on AAU’s advocacy for a $7.7 billion increase in NASA Science, Aeronautics and Exploration activities; $34 million additional for the Office of Earth Science and an increase of $39 million for the Office of Biological and Physical Research; specifically worked on continued funding for the Solar Probe which provides for the next mission at Johns Hopkins Applied Physics Laboratory, Space Department; the NSF budget of $6.4 billion with particular support for the graduate programs like the Graduate Research Fellowship and support for funding areas to support the Nanotechnology Consortium in Maryland; continued support from EPA for the Center for Urban Asthma Studies and $250 thousand to conduct a review of the Baltimore region air quality data. Supported funding requests made for East Baltimore Development Inc., funding requests for emergency preparedness, and funding request for operating room equipment. HR 4567/S.2537, “Homeland Security Act, 2005”: urged appropriations for a Science and Technology Directorate and new funding for science and technology as well as university-based research within the Homeland Security area. Bioterrorism – Homeland Security Act: expressed concern over the flow of funds designated for improvements to the medical emergency preparedness and response system. HR 4613/S.2559, “Department of Defense Appropriations Act, 2005”: worked on continued growth in support for DOD Science, with particular emphasis on basic (6.1) and applied (6.2) research; the proposed “devolvement” of certain S&T programs and the transfer of the National Security Education Program to DOE.

Monitored: HR 3261, “Database and Collections of Information Misappropriation Act” HR 2517, “Piracy Deterrence and Education Act of 2003” HR 107, “Digital Media Consumers' Rights Act of 2003” S.2560, “Inducing Infringement of Copyrights Act of 2004” Patent legislation The CREATE Act

Monitored: HR 3261, “Database and Collections of Information Misappropriation Act” HR 2517, “Piracy Deterrence and Education Act of 2003” HR 107, “Digital Media Consumers' Rights Act of 2003” S.2560, “Inducing Infringement of Copyrights Act of 2004” Patent legislation The CREATE Act NIH proposal regarding public access to articles resulting from sponsored research

Kept Maryland Delegation apprised of concerns associated with the growing Medicare population and the pressures this presents for the healthcare system. Continued to appeal to CMS to adjust the Medicare Sustainable Growth Rate (formula) SGR. Monitored the implementation of the Medicare Modernization Act. Tracking: HR 4903, "Medicare Advantage and Prescription Drug Accountability Act of 2004" S.2725, "Closing the Coverage Gap Act of 2004" S.2766, "Prescription Drug and Health Improvement Act of 2004" HR 4919, "Medicare Drug Card Guaranteed Savings Act" HR4898/S.2535, "Medicare Preventative Services Coverage Act of 2004" HR 4491, "Hobson amendment"

Kept Maryland Delegation apprised of concerns associated with the growing Medicare population and the pressures this presents for the healthcare system. Continued to appeal to CMS to adjust the Medicare Sustainable Growth Rate (formula) SGR. Met with HHS staff in the office of the Director for Medicare Services to discuss SGR and opportunities to design demo projects. Monitored the implementation of the Medicare Modernization Act. Tracking: HR 4903, "Medicare Advantage and Prescription Drug Accountability Act of 2004" S.2725, "Closing the Coverage Gap Act of 2004" S.2766, "Prescription Drug and Health Improvement Act of 2004" HR 4919, "Medicare Drug Card Guaranteed Savings Act" HR4898/S.2535, "Medicare Preventative Services Coverage Act of 2004" HR 4491, "Hobson amendment"

Kept Maryland Delegation apprised of concerns associated with the growing Medicare population and the pressures this presents for the healthcare system. Continued to appeal to CMS to adjust the Medicare Sustainable Growth Rate (formula) SGR. Met with HHS staff in the office of the Director for Medicare Services to discuss SGR and opportunities to design demo projects. Monitored the implementation of the Medicare Modernization Act. Tracking: HR 4903, "Medicare Advantage and Prescription Drug Accountability Act of 2004" S.2725, "Closing the Coverage Gap Act of 2004" S.2766, "Prescription Drug and Health Improvement Act of 2004" HR 4919, "Medicare Drug Card Guaranteed Savings Act" HR4898/S.2535, "Medicare Preventative Services Coverage Act of 2004" HR 4491, "Hobson amendment"

Kept Maryland Delegation apprised of concerns associated with the growing Medicare population and the pressures this presents for the healthcare system. Continued to appeal to CMS to adjust the Medicare Sustainable Growth Rate (formula) SGR. Monitored the implementation of the Medicare Modernization Act. Tracking: HR 4903, "Medicare Advantage and Prescription Drug Accountability Act of 2004" S.2725, "Closing the Coverage Gap Act of 2004" S.2766, "Prescription Drug and Health Improvement Act of 2004" HR 4919, "Medicare Drug Card Guaranteed Savings Act" HR4898/S.2535, "Medicare Preventative Services Coverage Act of 2004" HR 4491, "Hobson amendment"

HR 5006/S 2810**HR 4818, “Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2005”: worked on the following items: an increase of 10 percent to the National Institutes of Health budget; potential Toomey-type amendments in the FY 2005 Labor, Health and Human Services and Education Appropriations bill, which stands to alter the funding of certain NIH grant review processes; the advocacy effort for increased funding for extramural facilities construction through the National Institutes of Health. Supported funding request of $1.5 million for “OR-1” a state-of-the-art operating suite for use in minimally invasive surgery. Also supported funding request for Critical Event Preparedness and Response (CEPAR), to prepare the healthcare enterprise for potential critical events. Worked on expanding a variety of student financial assistance programs such as Pell Grant appropriation to $14 billion, $115 million increase to the Supplemental Educational Opportunities Grant, $157 million increase to Federal Work-Study, $40.6 million increase to the Perkins Loan Program, and increase to the GAANN/Javits fellowships. Supported expansion of the Nursing Reinvestment Act funding health professions appropriations within Labor, HHS appropriations bill. HR 4118/S *HR 4818, Energy and Water Development Appropriations Act, 2005”: Discussed maintenance of research funding at the National Science Foundation and at the Department of Energy with particular emphasis in investing in basic research. HR 5041/S. 2825**HR 4818 “Department of Veterans Affairs and Housing and Urban Development, and Independent Agencies Appropriations Act, 2005”: worked on AAU’s advocacy for a $7.7 billion increase in NASA Science, Aeronautics and Exploration activities; $34 million additional for the Office of Earth Science and an increase of $39 million for the Office of Biological and Physical Research; specifically worked on continued funding for the Solar Probe which provides for the next mission at Johns Hopkins Applied Physics Laboratory and for $2 million for 8 FTE for NASA Contract Office at APL, Space Department; the NSF budget of $6.4 billion with particular support for the graduate programs like the Graduate Research Fellowship and support for funding areas to support the Nanotechnology Consortium in Maryland; continued support from EPA for the Center for Urban Asthma Studies and $250 thousand to conduct a review of the Baltimore region air quality data. Supported funding requests made for East Baltimore Development Inc., funding requests for emergency preparedness, and funding request for operating room equipment. HR 4567/S 2537, “Homeland Security Act, 2005”: urged appropriations for a Science and Technology Directorate and new funding for science and technology as well as university-based research within the Homeland Security area. Bioterrorism – Homeland Security Act: expressed concern over the flow of funds designated for improvements to the medical emergency preparedness and response system. HR 4613/S 2559, “Department of Defense Appropriations Act, 2005”: worked on continued growth in support for DOD Science, with particular emphasis on basic (6.1) and applied (6.2) research; the proposed “devolvement” of certain S&T programs and the transfer of the National Security Education Program to DOE. HR4818/S 2812, “Foreign Operations, Export Financing, and related programs Appropriation Act, 2005”: worked on report language in support of the Center for Public Health and Human Rights.

HR 5006/S 2810**HR 4818, “Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2005”: worked on the following items: an increase of 10 percent to the National Institutes of Health budget; potential Toomey-type amendments in the FY 2005 Labor, Health and Human Services and Education Appropriations bill, which stands to alter the funding of certain NIH grant review processes; the advocacy effort for increased funding for extramural facilities construction through the National Institutes of Health. Supported funding request of $1.5 million for “OR-1” a state-of-the-art operating suite for use in minimally invasive surgery. Also supported funding request for Critical Event Preparedness and Response (CEPAR), to prepare the healthcare enterprise for potential critical events. Worked on expanding a variety of student financial assistance programs such as Pell Grant appropriation to $14 billion, $115 million increase to the Supplemental Educational Opportunities Grant, $157 million increase to Federal Work-Study, $40.6 million increase to the Perkins Loan Program, and increase to the GAANN/Javits fellowships. Supported expansion of the Nursing Reinvestment Act funding health professions appropriations within Labor, HHS appropriations bill. HR 4118/S *HR 4818, Energy and Water Development Appropriations Act, 2005”: Discussed maintenance of research funding at the National Science Foundation and at the Department of Energy with particular emphasis in investing in basic research. HR 5041/S. 2825**HR 4818 “Department of Veterans Affairs and Housing and Urban Development, and Independent Agencies Appropriations Act, 2005”: worked on AAU’s advocacy for a $7.7 billion increase in NASA Science, Aeronautics and Exploration activities; $34 million additional for the Office of Earth Science and an increase of $39 million for the Office of Biological and Physical Research; specifically worked on continued funding for the Solar Probe which provides for the next mission at Johns Hopkins Applied Physics Laboratory and for $2 million for 8 FTE for NASA Contract Office at APL, Space Department; the NSF budget of $6.4 billion with particular support for the graduate programs like the Graduate Research Fellowship and support for funding areas to support the Nanotechnology Consortium in Maryland; continued support from EPA for the Center for Urban Asthma Studies and $250 thousand to conduct a review of the Baltimore region air quality data. Supported funding requests made for East Baltimore Development Inc., funding requests for emergency preparedness, and funding request for operating room equipment. HR 4567/S 2537, “Homeland Security Act, 2005”: urged appropriations for a Science and Technology Directorate and new funding for science and technology as well as university-based research within the Homeland Security area. Bioterrorism – Homeland Security Act: expressed concern over the flow of funds designated for improvements to the medical emergency preparedness and response system. HR 4613/S 2559, “Department of Defense Appropriations Act, 2005”: worked on continued growth in support for DOD Science, with particular emphasis on basic (6.1) and applied (6.2) research; the proposed “devolvement” of certain S&T programs and the transfer of the National Security Education Program to DOE. HR4818/S 2812, “Foreign Operations, Export Financing, and related programs Appropriation Act, 2005”: worked on report language in support of the Center for Public Health and Human Rights.

HR 5006/S 2810**HR 4818, “Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2005”: worked on the following items: an increase of 10 percent to the National Institutes of Health budget; potential Toomey-type amendments in the FY 2005 Labor, Health and Human Services and Education Appropriations bill, which stands to alter the funding of certain NIH grant review processes; the advocacy effort for increased funding for extramural facilities construction through the National Institutes of Health. Supported funding request of $1.5 million for “OR-1” a state-of-the-art operating suite for use in minimally invasive surgery. Also supported funding request for Critical Event Preparedness and Response (CEPAR), to prepare the healthcare enterprise for potential critical events. Worked on expanding a variety of student financial assistance programs such as Pell Grant appropriation to $14 billion, $115 million increase to the Supplemental Educational Opportunities Grant, $157 million increase to Federal Work-Study, $40.6 million increase to the Perkins Loan Program, and increase to the GAANN/Javits fellowships. Supported expansion of the Nursing Reinvestment Act funding health professions appropriations within Labor, HHS appropriations bill. HR 4118/S *HR 4818, Energy and Water Development Appropriations Act, 2005”: Discussed maintenance of research funding at the National Science Foundation and at the Department of Energy with particular emphasis in investing in basic research. HR 5041/S. 2825**HR 4818 “Department of Veterans Affairs and Housing and Urban Development, and Independent Agencies Appropriations Act, 2005”: worked on AAU’s advocacy for a $7.7 billion increase in NASA Science, Aeronautics and Exploration activities; $34 million additional for the Office of Earth Science and an increase of $39 million for the Office of Biological and Physical Research; specifically worked on continued funding for the Solar Probe which provides for the next mission at Johns Hopkins Applied Physics Laboratory and for $2 million for 8 FTE for NASA Contract Office at APL, Space Department; the NSF budget of $6.4 billion with particular support for the graduate programs like the Graduate Research Fellowship and support for funding areas to support the Nanotechnology Consortium in Maryland; continued support from EPA for the Center for Urban Asthma Studies and $250 thousand to conduct a review of the Baltimore region air quality data. Supported funding requests made for East Baltimore Development Inc., funding requests for emergency preparedness, and funding request for operating room equipment. HR 4567/S 2537, “Homeland Security Act, 2005”: urged appropriations for a Science and Technology Directorate and new funding for science and technology as well as university-based research within the Homeland Security area. Bioterrorism – Homeland Security Act: expressed concern over the flow of funds designated for improvements to the medical emergency preparedness and response system. HR 4613/S 2559, “Department of Defense Appropriations Act, 2005”: worked on continued growth in support for DOD Science, with particular emphasis on basic (6.1) and applied (6.2) research; the proposed “devolvement” of certain S&T programs and the transfer of the National Security Education Program to DOE. HR4818/S 2812, “Foreign Operations, Export Financing, and related programs Appropriation Act, 2005”: worked on report language in support of the Center for Public Health and Human Rights.

HR 5041/S 2825*HR 4818, Supported the requests on behalf of the East Baltimore Development Inc. for the support in FY 2005 HUD/VA Appropriations bill for redevelopment activities including large-scale property acquisition and demolition; economic development and job creation as well as re-development of housing anchored by a biotech facility located near Johns Hopkins Hospital.

Monitored: HR 4682, “Stem Cell Research Enhancement Act of 2004” HR 4812, “Stem Cell Discovery Through Diversity Act" S.303, “Human Cloning Ban and Stem Cell Research Protection Act of 2003” HR 4531, “Ronald Reagan Memorial Stem Cell Research Act of 2004” S.2533/HR 4595, "Ronald Reagan Alzheimer's Breakthrough Act of 2004" (also discussed this bill with members of MD Delegation) HR 3960, “Stem Cell Replenishment Act of 2004” HR 2852, “Stem Cell Act of 2003” S.1717, “Cord Blood Stem Cell Act of 2003” Worked with the Coalition for the Advancement of Medical research to track such issues. Requested that Maryland Congressional Delegation sign letter appealing to President Bush to expand policy concerning stem cell research. Wrote to NIH regarding position on a request to invoke march-in proceedings for patent rights on two pharmaceuticals.

Monitored: HR 4682, “Stem Cell Research Enhancement Act of 2004” HR 4812, “Stem Cell Discovery Through Diversity Act" S.303, “Human Cloning Ban and Stem Cell Research Protection Act of 2003” HR 4531, “Ronald Reagan Memorial Stem Cell Research Act of 2004” S.2533/HR 4595, "Ronald Reagan Alzheimer's Breakthrough Act of 2004" (also discussed this bill with members of MD Delegation) HR 3960, “Stem Cell Replenishment Act of 2004” HR 2852, “Stem Cell Act of 2003” S.1717, “Cord Blood Stem Cell Act of 2003” Worked with the Coalition for the Advancement of Medical research to track such issues. Requested that Maryland Congressional Delegation sign letter appealing to President Bush to expand policy concerning stem cell research. Wrote to NIH regarding position on a request to invoke march-in proceedings for patent rights on two pharmaceuticals.

Communicated several issues concerning academic health centers to the Secretary of Health and Human Services and his office including: implementation of HIPAA rules, the development of regional electronic patient record systems, and concerns about physician reimbursement rates, medical liability, patient safety, bioterrorism and facilities and administration support. Worked in cooperation with AAMC and AHA to appeal to CMS to consider adjustments to the Medicare sustainable growth rate formula. Johns Hopkins is part of the Maryland/DC Collaborative for Healthcare Information Technology (formerly Maryland/DC E-Health Initiative) to develop and implement a regional electronic patient record system. Continue to keep all members of the Maryland Delegation apprised of the Collaborative’s progress. Monitored HR 663 and S.720, both Patient Safety and Quality Improvement Acts that create voluntary systems for tracking medical errors and promise confidentiality to hospitals and doctors; monitored HR 5, “Help Efficient, Accessible, Low-Cost, Timely Healthcare (HEALTH) Act of 2003,” that sets a cap on medical liability; and monitored any Congressional activity that may result from recent court decisions regarding patent infringement claims. Advocated funding and monitored NIH and NSF budgets along with the Association of American Universities (AAU) and Association of American Medical Colleges (AAMC)-see budget section. Monitored S.15, “Project BioShield Act of 2004” Monitored legislation and raised awareness of potential Toomey–type amendments, which would potentially alter the funding of specific NIH-sponsored research projects that had undergone the established peer review processes. Continue to monitor legislative efforts on patient safety, physician reimbursement rates, quality improvement and medical liability. Monitored the shortage of flu vaccine and attempts to obtain vaccine from Canada. Monitored NIH and Congressional review of the use of federal funds for HIV research in Uganda.

Communicated several issues concerning academic health centers to the Secretary of Health and Human Services and his office including: implementation of HIPAA rules, the development of regional electronic patient record systems, and concerns about physician reimbursement rates, medical liability, patient safety, bioterrorism and facilities and administration support. Worked in cooperation with AAMC and AHA to appeal to CMS to consider adjustments to the Medicare sustainable growth rate formula. Johns Hopkins is part of the Maryland/DC Collaborative for Healthcare Information Technology (formerly Maryland/DC E-Health Initiative) to develop and implement a regional electronic patient record system. Continue to keep all members of the Maryland Delegation apprised of the Collaborative’s progress. Monitored HR 663 and S.720, both Patient Safety and Quality Improvement Acts that create voluntary systems for tracking medical errors and promise confidentiality to hospitals and doctors; monitored HR 5, “Help Efficient, Accessible, Low-Cost, Timely Healthcare (HEALTH) Act of 2003,” that sets a cap on medical liability; and monitored any Congressional activity that may result from recent court decisions regarding patent infringement claims. Advocated funding and monitored NIH and NSF budgets along with the Association of American Universities (AAU) and Association of American Medical Colleges (AAMC)-see budget section. Monitored S.15, “Project BioShield Act of 2004” Monitored legislation and raised awareness of potential Toomey–type amendments, which would potentially alter the funding of specific NIH-sponsored research projects that had undergone the established peer review processes. Continue to monitor legislative efforts on patient safety, physician reimbursement rates, quality improvement and medical liability.

Monitored HR 107, the “Digital Media Consumers’ Rights Act of 2003", HR 2344, the “Intellectual Property Protection Restoration Act of 2003.”

Monitored the following bills: HR 3261, "Database and Collections of Information Misappropriation Act" HR 2417, "Piracy Deterrence and Education Act of 2003" HR 107, "Digital Media Consumers' Rights Act of 2003" Patent legislation The CREATE Act

Communicated several issues concerning academic health centers to the Secretary of Health and Human Services including: implementation of HIPAA rules and the development of electronic patient record systems, concerns about medical malpractice, bioterrorism and facilities funding. Specifically, Johns Hopkins is part of a Maryland/DC E-Health Initiative to devise a regional electronic patient record system; we are monitoring HR 663 and S 720, both Patient Safety and Quality Improvement Acts that create voluntary systems for tracking medical errors and promise confidentiality to hospitals and doctors; monitoring HR 5, “Help Efficient, Accessible, Low-Cost, Timely Healthcare (HEALTH) Act of 2003,") that sets a cap on medical liability; and monitoring any Congressional activity that may result from recent court decisions regarding patent infringement claims. Advocated for funding and monitored NIH and NSF budgets along with Association of American Medical Colleges (AAMC)–see budget section. Monitored S.1504/HR 2122, "Project BioShield Act of 2003," HCR 95,S. 1505 and HSA smallpox vaccination program implementation.

Advocated for funding and monitored NIH and NSF budgets along with Association of American Medical Colleges (AAMC)-see budget section. Monitored S.1504/HR 2122, “Project BioShield Act of 2003” HR 2660, “Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2004”: Worked on the Toomey admendment, which would have altered the funding of certain NIH grant review processes. Participated in meetings with Agency for Healthcare Research and Quality and the Veterans Administration as a member of the MD/DC Electronic Health Initiative. Met with a member of the President’s Information Technology Advisory Committee. This consortium is working to create a regional electronic health record system. In addition to meeting with agency representatives, kept Senators Mikulski and Sarbanes, as well as Congressman Cardin, apprised of the group’s plans and progress. Continue to monitor legislative efforts on patient safety, quality improvement and those working to address medical liability issues.

Monitored HR 107, the “Digital Media Consumers’ Rights Act of 2003", HR 2344, the “Intellectual Property Protection Restoration Act of 2003.”

Monitored the following: HR 801, the “Cloning Prohibition Act of 2003,” S.245, “Human Cloning Prohibition Act of 2003,” S.303, the “Human Cloning Ban and Stem Cell Research Protection Act of 2003,” HR 534, the “Human Cloning Prohibition Act of 2003,” HR 916, “Human Cloning Research Prohibition Act,” HR 2852, the “Cord Blood Stem Cell Act of 2003.” S.415, “Consumer Involvement in Breast Cancer Research Act,” S.314, “Foundation for the National Institutes of Health Improvement Act,” S.1717, “Cord Blood Stem Cell Act of 2003,” working with the Coalition for the Advancement of Medical research to track such issues.

Monitored HR 801, the "Cloning Prohibition Act of 2003," S.245, "Human Cloning Prohibition Act of 2003," S. 303, the "Human Cloning Ban and Stem Cell Research Protection Act of 2003," HR 534, the "Human Cloning Prohibition Act of 2003," HR 916, "Human Cloning Research Prohibition Act," and HR 2852, the "Stem Cell Act of 2003." Also, S.415, "Consumer Involvement in Breast Cancer Research Act," and S.314, "Foundation for the National Institutes of Health Improvement Act."

Monitored the following bills: HR 3261, "Database and Collections of Information Misappropriation Act" HR 2417, "Piracy Deterrence and Education Act of 2003" HR 107, "Digital Media Consumers' Rights Act of 2003" Patent legislation The CREATE Act

Communicated to the Maryland Congressional Delegation Johns Hopkins Medicine’s support of the Senate version of HJR 2, “Consolidated Appropriations Resolution, 2003,” to provide temporary relief for certain Medicare providers; joined AAMC to advocate a re-calculation of the Medicare Economic Index. Advocated for an amendment sponsored by Hutchison and Kennedy to restore Indirect Medical Education (IME) payment to 6.5 % level that Medicare paid until last fall as set forth by S. 899, “American Hospital Preservation Act of 2003.” Monitored the Senate and House Medicare prescription drug package and HR 328, “Access to Hospitals Act of 2003.” HR 1, “Medicare Prescription Drug and Modernization Act of 2003,” and S.1, “Prescription Drug and Medicare Improvement Act of 2003,”: worked on the CMS formula for physician payments, regulatory relief in negotiation of inpatient drugs at 340B hospitals; communicated with the Maryland Congressional Delegation and with the conferees concerning various aspects of the Medicare Prescription Drug Bill. Also addressed issues concerning the increase to a positive update of the physician Medicare payments; DSH relief provision and encouraged accelerated application of relief; competitive bidding for durable medical equipment (DME); home health co-payment; the reduction in the home health market basket update; the cut in hospital payments of market basket –0.4; hospital payment improvements; the inclusion of IME relief; competitive bidding nationwide to achieve more cost savings in home health care, and average wholesale pricing of certain drugs.

Communicated to the Maryland Congressional Delegation Johns Hopkins Medicine’s support of the Senate version of HJR 2, “Consolidated Appropriations Resolution, 2003,” to provide temporary relief for certain Medicare providers; joined AAMC to advocate a re-calculation of the Medicare Economic Index. Advocated for an amendment sponsored by Hutchison and Kennedy to restore Indirect Medical Education (IME) payment to 6.5% level that Medicare paid until last fall as set forth by S. 899, “American Hospital Preservation Act of 2003.” Monitored the Senate and House Medicare prescription drug package and HR 328, “Access to Hospitals Act of 2003.” HR 1, "Medicare Prescription Drug and Modernization Act of 2003," and S.1, "Prescription Drug and Medicare Improvement Act of 2003,":advocated on behalf of the CMS formula for physician payments, regulatory relief in negotiation of inpatient drugs at 340B hospitals, competitive bidding nationwide to achieve more cost savings in home health care, and average wholesale pricing of certain drugs.

Worked collaboratively with ACE, NAICU, NASULGC, and AAU to establish the university community positions on the Reauthorization of Higher Education Act, HR 6. Visited offices of all ten members of the Maryland Delegation. Worked on increased access to higher education for low-income students by strengthening support for grants and early intervention programs, particularly the Pell Grant program; increase in financial aid support for graduate education through GAANN, Javits and FLAS fellowship and grant programs; increased access to both undergraduate and graduate education by raising student loan borrowing limits and providing for more flexible means of calculating individual student aid packages; reducing the regulatory burden on universities; and ensuring accountability of institutions through an accreditation system and providing a decentralized system of higher education accreditation. Joined AAU and other universities in working on measures within HR 3311, Affordability in Higher Education Index.

Communicated several issues concerning academic health centers to the Secretary of Health and Human Services including: implementation of HIPAA rules and the development of electronic patient record systems, concerns about medical malpractice, bioterrorism and facilities funding. Specifically, Johns Hopkins is part of a Maryland/DC E-Health Initiative to devise a regional electronic patient record system; we are monitoring HR 663 and S 720, both Patient Safety and Quality Improvement Acts that create voluntary systems for tracking medical errors and promise confidentiality to hospitals and doctors; monitoring HR 5, “Help Efficient, Accessible, Low-Cost, Timely Healthcare (HEALTH) Act of 2003,") that sets a cap on medical liability; and monitoring any Congressional activity that may result from recent court decisions regarding patent infringement claims. Advocated for funding and monitored NIH and NSF budgets along with Association of American Medical Colleges (AAMC)–see budget section. Monitored S.1504/HR 2122, "Project BioShield Act of 2003," HCR 95,S. 1505 and HSA smallpox vaccination program implementation.

Monitored HR 801, the "Cloning Prohibition Act of 2003," S.245, "Human Cloning Prohibition Act of 2003," S. 303, the "Human Cloning Ban and Stem Cell Research Protection Act of 2003," HR 534, the "Human Cloning Prohibition Act of 2003," HR 916, "Human Cloning Research Prohibition Act," and HR 2852, the "Stem Cell Act of 2003." Also, S.415, "Consumer Involvement in Breast Cancer Research Act," and S.314, "Foundation for the National Institutes of Health Improvement Act."